Form 4: DocuSign Director Sells Shares After RSU Vesting
Insider Transaction Report
DocuSign Director Anna Marrs reported the vesting of 725 restricted stock units and the subsequent sale of 363 common shares under a Rule 10b5-1 plan.
Summary
- DocuSign Director Anna Marrs reported transactions involving the company's common stock.
- On December 4, 2025, 725 restricted stock units (RSUs) vested, converting into 725 shares of common stock at a price of $0.
- Following this, on December 5, 2025, Marrs sold 363 shares of common stock at a price of $64.5 per share.
- The sale was executed pursuant to a pre-arranged Rule 10b5-1 trading plan.
- After these transactions, Marrs beneficially owns 11,525 shares of common stock and 1,450 restricted stock units.
Sentiment
Score: 6
Explanation: The transaction is a routine insider sale, pre-planned under a 10b5-1 plan, which mitigates any negative sentiment typically associated with insider selling. The vesting of RSUs is a positive for the director.
Positives
- The vesting of 725 restricted stock units demonstrates continued compensation and alignment of the director's interests with shareholder value.
- The sale was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled liquidity event rather than a reaction to new, negative information.
Negatives
- A director selling shares, even under a pre-arranged plan, reduces their direct equity stake in the company.
Future Outlook
This filing does not contain forward-looking statements or guidance regarding the company's future performance.
Industry Context
Insider transactions, such as those reported on Form 4, are common for directors and executives managing their personal portfolios, often through pre-arranged Rule 10b5-1 plans to avoid accusations of trading on material non-public information. This is a routine disclosure for a publicly traded company.
Stakeholder Impact
- Shareholders: The sale of a relatively small number of shares by a director, especially under a 10b5-1 plan, is generally viewed as a routine liquidity event and is unlikely to significantly impact shareholder confidence.
Next Steps
- Remaining Restricted Stock Units (RSUs) will continue to vest in twelve equal quarterly installments over three years, subject to the reporting person's continued service.
Key Dates
| Date | Description |
|---|---|
| June 4, 2023 | Commencement date for the vesting of Restricted Stock Units (RSUs) in twelve equal quarterly installments over three years. |
| December 4, 2025 | Vesting of 725 Restricted Stock Units (RSUs) into common stock. |
| December 5, 2025 | Sale of 363 shares of common stock by Director Anna Marrs. |
Recommendation
holdThis Form 4 reports a routine insider transaction involving the vesting of restricted stock units and a subsequent sale of a small number of shares under a pre-arranged Rule 10b5-1 plan. Such transactions are common for executives managing personal liquidity and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation.
Keywords
DOCU, DocuSign, Form 4, insider trading, stock sale, RSU, restricted stock units, Anna Marrs, director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.